TABLE 2.
Culture site | No. of patients | MSSA positive | pSK41 MSSA positive | MRSA positive | pSK41 MRSA positive | VRE positive | MRSA and MSSA positive | Staphylococcus aureus and VRE positive |
---|---|---|---|---|---|---|---|---|
Any culture sitea Specific culture sites | 179 | 57 (32) | 3 (2) | 62 (35) | 5 (3) | 12 (7) | 7 (4)b | 7 (4)c |
Nares | 177 | 35 (20) | 2 (1) | 44 (25) | 3 (2) | NA | 0 (0) | 0 (0) |
Wound | 179 | 46 (26) | 1 (1) | 49 (27) | 2 (1) | 8 (4) | 0 (0) | 0 (0) |
Perirectal | 31 | 5 (16) | 1 (3) | 4 (13) | 1 (3) | 4 (13) | 0 (0) | 0 (0) |
NOTE. Data are no. (%) of patients. MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus; NA, not applicable; VRE, vancomycin-resistant enterococcus.
Includes results of any site cultured for each patient; of note, not all patients had all sites cultured.
None were positive for MRSA and MSSA at the same body site.
Four MRSA, 3 MSSA.